相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
Tjalling Bosse et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M. Cosgrove et al.
GYNECOLOGIC ONCOLOGY (2017)
Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma
Mariano Russo et al.
HUMAN PATHOLOGY (2017)
Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years
Antonios Anagnostopoulos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Antonia R. Sepulveda et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing
Jonathan A. Nowak et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
The genetic landscape of endometrial clear cell carcinomas
Deborah F. DeLair et al.
JOURNAL OF PATHOLOGY (2017)
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
Katherine C. Kurnit et al.
MODERN PATHOLOGY (2017)
Novel Implications in Molecular Diagnosis of Lynch Syndrome
Raffaella Liccardo et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition
Florine A. a Eggink et al.
ONCOIMMUNOLOGY (2017)
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Jeroen Depreeuw et al.
CLINICAL CANCER RESEARCH (2017)
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B. Campbell et al.
CELL (2017)
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
Ingvild L. Tangen et al.
BRITISH JOURNAL OF CANCER (2017)
Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing
Matthieu Le Gallo et al.
CANCER (2017)
Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis
Inigo Espinosa et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Integrated Molecular Characterization of Uterine Carcinosarcoma
Andrew D. Cherniack et al.
CANCER CELL (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy
Salwa Bakhsh et al.
HISTOPATHOLOGY (2016)
Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma
Jaclyn C. Watkins et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
Louis J. M. van der Putten et al.
BRITISH JOURNAL OF CANCER (2016)
Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab
Alessandro D. Santin et al.
CLINICAL CANCER RESEARCH (2016)
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
Melissa K. McConechy et al.
CLINICAL CANCER RESEARCH (2016)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma
T. P. Batista et al.
EJSO (2016)
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
Martin Kobel et al.
GYNECOLOGIC ONCOLOGY (2016)
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
Aline Talhouk et al.
GYNECOLOGIC ONCOLOGY (2016)
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers
Anne M. Schultheis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Janice M. Mehnert et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels
Zsofia K. Stadler et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas (vol 29, pg 1390, 2016)
Juanm M. Rosa-Rosa et al.
MODERN PATHOLOGY (2016)
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
Inge C. Van Gool et al.
MODERN PATHOLOGY (2016)
Neoepitopes and CD3-Positive and CD8-Positive Cells in Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers
Inge C. van Gool et al.
JAMA ONCOLOGY (2016)
A panoply of errors: polymerase proofreading domain mutations in cancer
Emily Rayner et al.
NATURE REVIEWS CANCER (2016)
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
Martin Kobel et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
S. Bendifallah et al.
BRITISH JOURNAL OF CANCER (2015)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
Inge C. van Gool et al.
CLINICAL CANCER RESEARCH (2015)
Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas
M. K. McConechy et al.
GYNECOLOGIC ONCOLOGY (2015)
Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria
Tae Wook Kong et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo et al.
MODERN PATHOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
Brooke E. Howitt et al.
JAMA ONCOLOGY (2015)
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
Yaser R. Hussein et al.
MODERN PATHOLOGY (2015)
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
T. Bosse et al.
EUROPEAN JOURNAL OF CANCER (2014)
Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis
Aga Syed Sameer et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2014)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication
Eve Shinbrot et al.
GENOME RESEARCH (2014)
A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial
D. S. McMeekin et al.
GYNECOLOGIC ONCOLOGY (2014)
Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer
Mariam M. AlHilli et al.
GYNECOLOGIC ONCOLOGY (2014)
DNA Polymerase ε and Its Roles in Genome Stability
Erin E. Henninger et al.
IUBMB LIFE (2014)
Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
Yuexin Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
Sian Jones et al.
NATURE COMMUNICATIONS (2014)
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
C. Blake Gilks et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
N. Colombo et al.
ANNALS OF ONCOLOGY (2013)
Lack of Estrogen Receptor-α Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Elisabeth Wik et al.
CLINICAL CANCER RESEARCH (2013)
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
Jone Trovik et al.
EUROPEAN JOURNAL OF CANCER (2013)
DNA polymerase ? and exonuclease domain mutations in endometrial cancer
David N. Church et al.
HUMAN MOLECULAR GENETICS (2013)
L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
Alain G. Zeimet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Reproducibility of histological cell type in high-grade endometrial carcinoma
Guangming Han et al.
MODERN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤70 years
Celine H. M. Leenen et al.
GYNECOLOGIC ONCOLOGY (2012)
Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
Scott M. Weissman et al.
JOURNAL OF GENETIC COUNSELING (2012)
Endometrial Carcinomas: A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features
Carla Bartosch et al.
ADVANCES IN ANATOMIC PATHOLOGY (2011)
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
Anna Yemelyanova et al.
MODERN PATHOLOGY (2011)
Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible A Transcanadian Study
Martin Koebel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
Abdulmohsen Alkushi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis
Yukiharu Todo et al.
LANCET (2010)
Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma
Geoffrey Hall et al.
PATHOLOGY (2010)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
Are Uterine Risk Factors More Important Than Nodal Status in Predicting Survival in Endometrial Cancer?
Janice S. Kwon et al.
OBSTETRICS AND GYNECOLOGY (2009)
Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging
Andrea Mariani et al.
GYNECOLOGIC ONCOLOGY (2008)
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Nobuyuki Susumu et al.
GYNECOLOGIC ONCOLOGY (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C. Blake Gilks et al.
HUMAN PATHOLOGY (2008)
Ubiquitination and degradation of mutant p53
Natalia Lukashchuk et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
R. Maggi et al.
BRITISH JOURNAL OF CANCER (2006)
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis
Michelle Reid-Nicholson et al.
MODERN PATHOLOGY (2006)
The multifaceted mismatch-repair system
J Jiricny
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome
KH Lu et al.
OBSTETRICS AND GYNECOLOGY (2005)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
The 3′-5′ exonucleases
IV Shevelev et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Steady-state regulation of the human DNA mismatch repair system
DK Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
分享论文
